 Alpine Immune Sciences NASDAQ:ALPN and Nabriva Therapeutics NASDAQ:NBRV are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Risk Volatility Alpine Immune Sciences has a beta of 1.31, meaning that its ... 